A Direct Comparison of IV and ICV Delivery Methods for Gene Replacement Therapy in a Mouse Model of SMARD1

Grohmann, 2003, Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1), Ann. Neurol., 54, 719, 10.1002/ana.10755 Rudnik-Schöneborn, 2004, Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1), Neuropediatrics, 35, 174, 10.1055/s-2004-820994 Grohmann, 1999, Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form Is linked to chromosome 11q13-q21, Am. J. Hum. Genet., 65, 1459, 10.1086/302636 Grohmann, 2001, Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1, Nat. Genet., 29, 75, 10.1038/ng703 Lim, 2012, The Ighmbp2 helicase structure reveals the molecular basis for disease-causing mutations in DMSA1, Nucleic Acids Res., 40, 11009, 10.1093/nar/gks792 Viollet, 2002, Mapping of autosomal recessive chronic distal spinal muscular atrophy to chromosome 11q13, Ann. Neurol., 51, 585, 10.1002/ana.10182 Fukita, 1993, The human S mu bp-2, a DNA-binding protein specific to the single-stranded guanine-rich sequence related to the immunoglobulin mu chain switch region, J. Biol. Chem., 268, 17463, 10.1016/S0021-9258(19)85357-7 de Planell-Saguer, 2009, Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery, Hum. Mol. Genet., 18, 2115, 10.1093/hmg/ddp134 Guenther, 2009, IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1), Hum. Mol. Genet., 18, 1288, 10.1093/hmg/ddp028 Molnar, 1997, Association of the mammalian helicase MAH with the pre-mRNA splicing complex, Proc. Natl. Acad. Sci. USA, 94, 7831, 10.1073/pnas.94.15.7831 Chen, 1997, Evidence for regulation of transcription and replication of the human neurotropic virus JCV genome by the human S(mu)bp-2 protein in glial cells, Gene, 185, 55, 10.1016/S0378-1119(96)00630-0 Miao, 2000, The rat ortholog of the presumptive flounder antifreeze enhancer-binding protein is a helicase domain-containing protein, Eur. J. Biochem., 267, 7237, 10.1046/j.1432-1327.2000.01836.x Zhang, 1999, Smubp-2 represses the Epstein-Barr virus lytic switch promoter, Virology, 255, 160, 10.1006/viro.1998.9588 Cox, 1998, Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele, Neuron, 21, 1327, 10.1016/S0896-6273(00)80652-2 Cook, 1995, Neuromuscular degeneration (nmd): a mutation on mouse chromosome 19 that causes motor neuron degeneration, Mamm. Genome, 6, 187, 10.1007/BF00293010 Grohmann, 2004, Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1), Hum. Mol. Genet., 13, 2031, 10.1093/hmg/ddh222 Krieger, 2014, Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1, Brain, 137, 1374, 10.1093/brain/awu059 Shababi, 2016, Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent, Mol. Ther., 24, 855, 10.1038/mt.2016.33 Maddatu, 2005, Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survival, Hum. Mol. Genet., 14, 3179, 10.1093/hmg/ddi349 Maddatu, 2004, Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy, Hum. Mol. Genet., 13, 1105, 10.1093/hmg/ddh129 Nizzardo, 2015, Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model, Sci. Adv., 1, e1500078, 10.1126/sciadv.1500078 Burge, 1999, 525 Fan, 2012, Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease, Fibrogenesis Tissue Repair, 5, 15, 10.1186/1755-1536-5-15 Szabó, 2014, Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure, Hypertension, 63, 1235, 10.1161/HYPERTENSIONAHA.114.03279 Borthwick, 2013, Cytokine mediated tissue fibrosis, Biochim. Biophys. Acta, 1832, 1049, 10.1016/j.bbadis.2012.09.014 Campbell, 1997, Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts, J. Mol. Cell. Cardiol., 29, 1947, 10.1006/jmcc.1997.0435 Chen, 2009, Functions and mechanisms of action of CCN matricellular proteins, Int. J. Biochem. Cell Biol., 41, 771, 10.1016/j.biocel.2008.07.025 Frangogiannis, 2012, Matricellular proteins in cardiac adaptation and disease, Physiol. Rev., 92, 635, 10.1152/physrev.00008.2011 Way, 2002, Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes, Diabetes, 51, 2709, 10.2337/diabetes.51.9.2709 Shababi, 2010, Cardiac defects contribute to the pathology of spinal muscular atrophy models, Hum. Mol. Genet., 19, 4059, 10.1093/hmg/ddq329 Heier, 2010, Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice, Hum. Mol. Genet., 19, 3906, 10.1093/hmg/ddq330 Bevan, 2010, Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery, Hum. Mol. Genet., 19, 3895, 10.1093/hmg/ddq300 Finsterer, 2000, Cardiac involvement in primary myopathies, Cardiology, 94, 1, 10.1159/000007039 Shababi, 2014, Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?, J. Anat., 224, 15 Hamilton, 2013, Spinal muscular atrophy: going beyond the motor neuron, Trends Mol. Med., 19, 40, 10.1016/j.molmed.2012.11.002 Glascock, 2011, Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice, J. Vis. Exp., 10.3791/2968 Shababi, 2012, Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy, J. Mol. Cell. Cardiol., 52, 1074, 10.1016/j.yjmcc.2012.01.005 Villalón, 2018, Selective vulnerability in neuronal populations in nmd/SMARD1 mice, Hum. Mol. Genet., 27, 679, 10.1093/hmg/ddx434 Habibi, 2017, Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes, Cardiovasc. Diabetol., 16, 9, 10.1186/s12933-016-0489-z Shababi, 2011, Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy, Hum. Gene Ther., 22, 135, 10.1089/hum.2010.114 Shababi, 2012, Optimization of SMN trans-splicing through the analysis of SMN introns, J. Mol. Neurosci., 46, 459, 10.1007/s12031-011-9614-3